Table 3 |
||||||||||
|
Association of C/T polymorphism of the GDF5 gene with CDH when stratified by gender |
||||||||||
|
Groups compared |
TT vs. other combined |
CC vs. other combined |
T allele vs. C allele |
All genotype |
||||||
|
|
|
|
|
|||||||
|
OR |
P value |
95% CI |
OR |
P value |
95% CI |
OR |
P value |
95% CI |
P value |
|
|
|
||||||||||
|
All patients (n = 338) vs all controls (n = 622) |
1.41 |
0.013 |
1.08 to 1.85 |
0.50 |
0.029 |
0.27 to 0.94 |
1.40 |
0.0037 |
1.11 to 1.75 |
0.014 |
|
Female patients (n = 291) vs female controls (n = 316) |
1.52 |
0.012 |
1.10 to 2.10 |
0.50 |
0.061 |
0.24 to 1.05 |
1.46 |
0.0053 |
1.21 to 1.91 |
0.020 |
|
Male patients (n = 47) vs male controls (n = 306) |
1.24 |
0.51 |
0.66 to 2.33 |
0.55 |
0.42 |
0.12 to 2.40 |
1.27 |
0.38 |
0.75 to 2.14 |
0.65 |
|
|
||||||||||
|
CDH = congenital dysplasia of the hip; CI = confidence interval; GDF5 = growth differentiate factor 5; OR = odds ratio. |
||||||||||
|
Dai et al. Arthritis Research & Therapy 2008 10:R126 doi:10.1186/ar2540 |
||||||||||